How does aspirin affect bleeding risk?

How Aspirin Increases Bleeding Risk

Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1) enzymes in platelets, blocking thromboxane A2 production. This impairs platelet aggregation and prolongs bleeding time for the platelet's lifespan (7-10 days), even after a single dose. Effects peak within hours and persist, raising risks for gastrointestinal, intracranial, and surgical bleeding.[1][2]

Common Bleeding Risks by Site

• Gastrointestinal: Aspirin erodes the mucosal barrier, increasing ulcer and bleed risk 2-4 fold at daily doses over 325 mg. Low-dose (81 mg) therapy still elevates risk by 50-60%.[3]
  
• Intracranial: Doubles hemorrhagic stroke risk in high-risk patients, especially with hypertension or prior stroke.[4]
  
• Surgical/trauma: Delays hemostasis; guidelines recommend stopping 7-10 days pre-surgery for non-cardiac procedures.[5]
  
  

Dose and Duration Effects

Low-dose aspirin (75-325 mg daily) for cardiovascular prevention mildly elevates risk (1.5-2x baseline) but benefits often outweigh harms in secondary prevention. Higher doses (>325 mg) or long-term use amplify risks exponentially. Enteric-coated forms reduce GI irritation but not systemic bleeding effects.[1][6]

Who Faces Higher Risks

• Elderly (over 75): 3-5x higher GI bleed risk due to reduced renal clearance and comorbidities.[3]
  
• Patients on anticoagulants (e.g., warfarin, DOACs): Combined use multiplies bleed risk 2-10x; triple therapy with clopidogrel is riskiest.[7]
  
• Ulcer history, NSAID users, or alcohol consumers: Synergistic effects boost odds.[2]
  
• No major increase in healthy young adults at low doses.[4]
  
  

Reversing or Managing Aspirin's Effects

Platelet transfusion restores function (1-2 units for urgent cases). Desmopressin shortens bleeding time in mild cases. Avoid PPIs alone for GI protection—combine with dose minimization. Effects wane as new platelets form (full recovery in 5-7 days).[5][8]

Clinical Guidelines and Balancing Benefits

ACCP and AHA recommend low-dose aspirin for high CV risk but advise against primary prevention in low-risk adults over 70 due to bleed outweighing benefits. Screen for H. pylori and use PPIs in at-risk groups.[6][9]

Sources
[1]: NEJM: Aspirin and Platelet Function
[2]: PubMed: Aspirin and Bleeding Risks
[3]: Lancet: GI Bleeding with Aspirin
[4]: Stroke: Aspirin and Hemorrhagic Risk
[5]: AABB Platelet Guidelines
[6]: USPSTF Aspirin Recommendations
[7]: NEJM: Anticoagulants + Aspirin
[8]: Blood: Managing Aspirin Bleeding
[9]: AHA/ACC Guidelines